Eddy N B, Friebel H, Hahn K J, Halbach H
Bull World Health Organ. 1968;38(5):673-741.
This report-the first of a series on codeine and its alternates for pain and cough relief-presents a detailed evaluation of experimental and clinical data concerning the analgesic action of codeine (the antitussive action will be assessed separately). The authors discuss the pharmacology of the drug, including side-effects and toxicity; effects on the respiratory, circulatory, digestive and urinary systems; tolerance, dependence and liability to abuse; metabolic effects; and mechanism of action.Though codeine is generally more toxic than morphine to animals on account of its convulsant action, it is less toxic to man, possibly because it produces less respiratory depression. Again, tolerance to its analgesic effects has been demonstrated in several animal species, but dependence in man is observed far less frequently than it is with morphine, and the abstinence syndrome is less intense. From their extensive review of the evidence available, the authors conclude that codeine is a good analgesic and that little risk to public health is likely to arise from its clinical use to relieve pain.
本报告是关于可待因及其用于止痛和止咳的替代药物系列报告中的第一篇,详细评估了有关可待因镇痛作用的实验和临床数据(止咳作用将另行评估)。作者讨论了该药物的药理学,包括副作用和毒性;对呼吸、循环、消化和泌尿系统的影响;耐受性、依赖性和滥用倾向;代谢作用;以及作用机制。尽管由于可待因的惊厥作用,它对动物的毒性通常比吗啡更大,但对人类的毒性较小,这可能是因为它产生的呼吸抑制作用较小。此外,在几种动物物种中已证明对其镇痛作用存在耐受性,但在人类中观察到的依赖性远低于吗啡,且戒断综合征的强度也较小。通过对现有证据的广泛审查,作者得出结论,可待因是一种良好的镇痛药,其临床用于缓解疼痛对公众健康可能产生的风险很小。